CME Group (CME) PT Raised to $220 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CME Hot Sheet
Price: $308.27 +1.38%
Rating Summary:
14 Buy, 11 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
14 Buy, 11 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
UBS analyst Alex Kramm raised the price target on CME Group (NASDAQ: CME) to $220.00 (from $214.00) while maintaining a Neutral rating.
You May Also Be Interested In
- CME Group posts record October ADV of 30M contracts, up 15%
- Procore Technologies, Inc (PCOR) PT Raised to $90 at BTIG
- CME Group Reports Record October ADV of 30 Million Contracts, up 15% Year Over Year
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
